Newsroom
Latest updates and announcements from Emmes Group
The Emmes Group Newsroom features updates on the work we're doing to advance clinical research and public health. Here you'll find news about partnerships, contract awards, technology innovations, leadership appointments, industry recognition, and expert perspectives. It's where we share how our global teams are shaping the future of clinical research.
Press releases
Stay informed with our latest announcements, including strategic collaborations, service expansions, and major milestones across the Emmes Group.
August 24, 2026
The Emmes Group Appoints Dr. Rama Kondru as Chief Executive Officer
ROCKVILLE, Maryland — The Emmes Group today announced that its Board of Directors has appointed Dr. Rama Kondru as Chief Executive Officer, reflecting the company’s commitment to advancing next-generation clinical trials that improve quality, speed, and patient outcomes.
Read more
November 25, 2025
Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil®
Dr John Levine, Chair of the BMT CTN Steering Committee and Professor of Internal Medicine and Pediatrics, Icahn School of Medicine at Mount Sinai, New York said: “We are delighted to be partnering with Mesoblast in this pivotal Phase 3…
Read moreMay 14, 2025
Rockville-Based CRO Emmes Groups’ OptymEdge launch the first dedicated ophthalmology clinical trial platform at ARVO
OptymEdge has long-standing expertise in visual function endpoints and certification and is leveraging this experience to reimagine and streamline processes across complex ophthalmology trials.
Read moreFebruary 12, 2025
Emmes Group Earns ISO 27001:2022 Certification for Data Security
The commendation from the International Organization for Standardization (ISO) underscores Emmes Group’s dedication to delivering secure, innovative, and data-driven solutions to its biotech and pharmaceutical partners.
Read moreJanuary 14, 2025
Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma
[Emmes Group](https://www.theemmesgroup.com/)®, a leading specialty tech and AI-enabled global contract research organization (CRO), today announced the appointment of Germaine Gross to the role of Chief Commercial Officer,…
Read moreJanuary 8, 2025
Essex Management Appoints David Loose as Chief Executive Officer
David Loose joined Essex Management as a partner in February 2009 and has played a pivotal role in the company’s growth. Starting as Vice President for Business Operations and Development, he later served as Chief Business Officer,…
Read moreIn the news
Explore recent media coverage highlighting our impact on the clinical research landscape — from global health initiatives to AI innovation in clinical trials.
Building an AI-native CRO
Read more
September 17, 2026
Lessons from Hundreds of Clinical Trials: AI’s Successes, Gaps, and Opportunities
Read more
February 7, 2026
Novel stem cell therapy to treat central retinal vein occlusion
Read more
December 30, 2025
FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia
Read moreNovember 25, 2025
Essex Management Appoints David Loose as Chief Executive Officer
Read moreJune 30, 2025
Emmes CEO on AI in clinical research
Read moreMedia Contact
For interviews, press materials, or questions about Emmes Group, reach out to our communications team. Media line: +1 202-380-5168.